Budenofil 9 Tablet CR
Marketer
Fourrts India Laboratories Pvt Ltd
Salt Composition
Budesonide (9mg)
Overview Budenofil 9 Tablet CR
Corticosteroid Budenofil 9 CR tablets are indicated for managing moderate-to-severe ulcerative colitis. This medication, a steroid, alleviates inflammation and pain associated with the disease. Budenofil 9 CR can be administered with or without food; consistent, daily dosing at the same time each day maximizes therapeutic effects. Stopping treatment prematurely without consulting your physician may exacerbate symptoms. While generally well-tolerated, potential side effects include gastrointestinal discomfort and mood alterations. Furthermore, Budenofil 9 CR may compromise immune function, increasing susceptibility to infections. Report any infection indicators, like fever or throat pain, to your doctor immediately.
Uses of Budenofil 9 Tablet CR
Managing ulcerative colitis
Major Benefits of Budenofil 9 Tablet CR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Budenofil 9 Tablet CR can be consumed with or without food; however, consistent daily timing is recommended.
Common Side effects of Budenofil 9 Tablet CR:
- Abdominal pain
- Constipation
- Headache
- Depression
- Joint pain
- Increased risk of infection
- Muscle pain
- Muscle weakness
- Muscle twitching
- Irritability
- Nausea
How to use Budenofil 9 Tablet CR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Budenofil 9 Tablet CR can be consumed with or without food, although consistent timing is recommended.
How Budenofil 9 Tablet CR works:
Budenofil 9 CR tablets contain a steroid that inhibits the release of inflammatory mediators. This action prevents ulceration and swelling of the large intestine's lining (colon and rectum), thus alleviating associated pain.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol concurrently with Budenofil 9 Tablet CR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Budenofil 9 CR tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Budenofil 9 Tablet CR while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Budenofil 9 Tablet CR on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Use of Budenofil 9 Tablet CR in individuals with kidney disease appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Budenofil 9 CR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Budenofil 9 CR tablets are contraindicated in individuals with severe hepatic dysfunction due to insufficient supporting clinical evidence.
What if you forget to take Budenofil 9 Tablet CR :
Should you forget a Budenofil 9 Tablet CR dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Budenofil 9 Tablet CR
| Label | Value |
|---|---|
| Chemical Category | Inhaled corticosteroids |
| Developing Habits | No. |
| Type of Therapy | Gastrointestinal system |



